Kaji H - Search Results

1

Imaging mass spectrometry for toxicity assessment: a useful technique to confirm drug distribution in histologically confirmed lesions.

Kashimura A, Tanaka K, Sato H, Kaji H, Tanaka M. Kashimura A, et al. Among authors: kaji h. J Toxicol Pathol. 2018 Jul;31(3):221-227. doi: 10.1293/tox.2018-0006. Epub 2018 May 3. J Toxicol Pathol. 2018. PMID: 30093793 Free PMC article.

2

Imaging Mass Spectrometry (IMS) for drug discovery and development survey: Results on methods, applications and regulatory compliance.

Solon E, Groseclose MR, Ho S, Tanaka K, Nakada N, Linehan S, Nishidate M, Yokoi H, Kaji H, Urasaki Y, Watanabe K, Ishida T, Komatsu R, Yoshida K, Yamazaki H, Saito K, Saito Y, Tanaka Y. Solon E, et al. Among authors: kaji h. Drug Metab Pharmacokinet. 2022 Apr;43:100438. doi: 10.1016/j.dmpk.2021.100438. Epub 2021 Dec 16. Drug Metab Pharmacokinet. 2022. PMID: 35091331

3

Binding of dihydrostreptomycin to ribosomal subunits.

Kaji H, Tanaka Y. Kaji H, et al. J Mol Biol. 1968 Mar 14;32(2):221-30. doi: 10.1016/0022-2836(68)90006-5. J Mol Biol. 1968. PMID: 4171195 No abstract available.

4

The role of ribosomal protein for the binding of dihydrostreptomycin to ribosomes.

Tanaka Y, Kaji H. Tanaka Y, et al. Among authors: kaji h. Biochem Biophys Res Commun. 1968 Jul 26;32(2):313-9. doi: 10.1016/0006-291x(68)90387-2. Biochem Biophys Res Commun. 1968. PMID: 4175012 No abstract available.

5

Incorporation of arginine by soluble extracts of ascites tumor cells and regenerating rat liver.

Tanaka Y, Kaji H. Tanaka Y, et al. Among authors: kaji h. Cancer Res. 1974 Sep;34(9):2204-8. Cancer Res. 1974. PMID: 4843529 No abstract available.

6

Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the glucuronidation of 2-(4-chlorophenyl)- 5-(2-furyl)-4-oxazoleacetic acid (TA-1801A).

Kaji H, Kume T. Kaji H, et al. Drug Metab Pharmacokinet. 2005 Jun;20(3):212-8. doi: 10.2133/dmpk.20.212. Drug Metab Pharmacokinet. 2005. PMID: 15988124 Free article.

7

Glucuronidation of 2-(4-chlorophenyl)-5-(2-furyl)-4-oxazoleacetic acid (TA-1801A) in humans: species differences in liver and intestinal microsomes.

Kaji H, Kume T. Kaji H, et al. Drug Metab Pharmacokinet. 2005 Jun;20(3):206-11. doi: 10.2133/dmpk.20.206. Drug Metab Pharmacokinet. 2005. PMID: 15988123 Free article.

8

Characterization of afloqualone N-glucuronidation: species differences and identification of human UDP-glucuronosyltransferase isoform(s).

Kaji H, Kume T. Kaji H, et al. Drug Metab Dispos. 2005 Jan;33(1):60-7. doi: 10.1124/dmd.104.001925. Epub 2004 Oct 8. Drug Metab Dispos. 2005. PMID: 15475412

9

Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.

Kaji H, Kume T. Kaji H, et al. Drug Metab Dispos. 2005 Mar;33(3):403-12. doi: 10.1124/dmd.104.002667. Epub 2004 Dec 17. Drug Metab Dispos. 2005. PMID: 15608137

10

Assessment of Risk of Acidosis in Patients with Mild-to-Moderate Chronic Kidney Disease Treated with Intravenous Branched-Chain Amino Acid-Enriched Solution: A Propensity Score Matching Analysis.

Kaji H, Yokooji T, Taogoshi T, Izumitani S, Hida E, Matsuo H. Kaji H, et al. Biol Pharm Bull. 2025;48(1):46-50. doi: 10.1248/bpb.b24-00569. Biol Pharm Bull. 2025. PMID: 39864851 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

869 results

Search Page

Filters